Quince Therapeutics, Inc. — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | — | 0001415889-24-003981 | Feb 15, 2024 | — |
| 8-K | 8-K | 0001193125-24-037521 | Feb 15, 2024 | Feb 13, 2024 |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-002876 | Feb 14, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-013830 | Feb 12, 2024 | — |
| SC 13G/A | — | 0001616824-24-000021 | Feb 7, 2024 | — |
| 4 | — | 0001415889-24-002378 | Feb 2, 2024 | Feb 1, 2024 |
| 4 | — | 0001415889-24-002379 | Feb 2, 2024 | Feb 1, 2024 |
| 4 | — | 0001415889-24-002380 | Feb 2, 2024 | Feb 1, 2024 |
| 8-K | 8-K | 0001193125-24-018071 | Jan 29, 2024 | Jan 23, 2024 |
| 4 | — | 0001415889-24-001313 | Jan 17, 2024 | Jan 16, 2024 |
| 8-K/A | 8-K/A | 0001193125-24-003344 | Jan 5, 2024 | Oct 20, 2023 |
| 8-K | 8-K | 0001193125-24-001482 | Jan 3, 2024 | Dec 29, 2023 |
| 8-K | 8-K | 0001193125-23-302116 | Dec 22, 2023 | — |
| SC 13G | SC 13G | 0001140361-23-057682 | Dec 15, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-058694 | Dec 14, 2023 | Dec 12, 2023 |
| 8-K | 8-K | 0001193125-23-291671 | Dec 8, 2023 | Dec 4, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-057799 | Dec 7, 2023 | Dec 5, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-057053 | Dec 1, 2023 | Nov 29, 2023 |
| 10-Q | 10-Q | 0000950170-23-063716 | Nov 14, 2023 | Sep 30, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-053695 | Oct 26, 2023 | Oct 24, 2023 |
| 8-K | 8-K | 0001193125-23-264057 | Oct 26, 2023 | Oct 24, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-053505 | Oct 24, 2023 | Oct 23, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-053508 | Oct 24, 2023 | Oct 23, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-053509 | Oct 24, 2023 | Oct 23, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-053510 | Oct 24, 2023 | Oct 23, 2023 |
| 8-K | 8-K | 0001193125-23-260785 | Oct 23, 2023 | Oct 20, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048483 | Sep 6, 2023 | Sep 1, 2023 |
| 8-K | 8-K | 0001193125-23-229101 | Sep 6, 2023 | Aug 30, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-048477 | Sep 6, 2023 | Sep 1, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-047880 | Aug 31, 2023 | Aug 30, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046402 | Aug 17, 2023 | Aug 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-045432 | Aug 11, 2023 | Aug 10, 2023 |
| 8-K | 8-K | 0001193125-23-209172 | Aug 10, 2023 | Aug 4, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-045235 | Aug 9, 2023 | Aug 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-045234 | Aug 9, 2023 | Aug 8, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-045231 | Aug 9, 2023 | Aug 8, 2023 |
| 10-Q | 10-Q | 0000950170-23-038042 | Aug 3, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-191839 | Jul 24, 2023 | Jul 21, 2023 |
| SC 13G | NONE | 0001567619-23-006604 | Jul 17, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-032681 | May 26, 2023 | May 24, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-032679 | May 26, 2023 | May 24, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-032671 | May 26, 2023 | May 24, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-032677 | May 26, 2023 | May 24, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-032674 | May 26, 2023 | May 24, 2023 |
| 8-K | 8-K | 0001193125-23-154245 | May 25, 2023 | May 24, 2023 |
| 10-Q | 10-Q | 0000950170-23-022241 | May 15, 2023 | Mar 31, 2023 |
| DEF 14A | DEF 14A | 0001193125-23-102037 | Apr 14, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-23-102054 | Apr 14, 2023 | — |
| ARS | ARS | 0001193125-23-102069 | Apr 14, 2023 | Dec 31, 2022 |
| 8-A12B | 8-A12B | 0001193125-23-092432 | Apr 5, 2023 | — |